InsidersTradesSigma
Explore the detailed record of transactions filed by Broom Colin MD, Director. Officer active across 1 companies, notably Nabriva Therapeutics plc. In total, 4 filings have been recorded. Total volume traded: €1k. The latest transaction was filed on 2 August 2021 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
4 of 4 declarations
Broom Colin MD is a Board Member at Nabriva Therapeutics plc. In this role, he brings his expertise in biotechnology and healthcare, contributing to the strategic direction of the company. His experience in pharmaceutical research and development is a valuable asset to the board, guiding decisions related to innovation and regulatory compliance.